Instil Bio, Inc.
NASDAQ:TILBiotechnology
Healthcare
$7.45 +0.13%
+$0.01 today
- Market cap
- $50.53M
- Beta
- 1.91
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$6.99
52W Low $5.67High $33.83
Volume 0.02M
Average 0.03M
Balance Sheet
Inspect the capital base behind the business.
Assets
$203.52M
FY 2025 · Annual
-22.8% YoYLiabilities
$89.66M
FY 2025 · Annual
-4.8% YoYEquity
$113.87M
FY 2025 · Annual
-32.8% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 37.59M | 43.72M | 9.2M | 8.81M | 6.64M |
| Short-term Investments | 416.51M | 217.2M | 141.16M | 104.51M | 69.49M |
| Net Receivables | 0 | 0 | 0 | 0 | 848K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 8.46M | 1.5M | 1.83M | 112.41M |
| Total Current Assets | 464.02M | 269.38M | 160.76M | 124.47M | 191.43M |
| Property, Plant & Equipment (Net) | 122M | 209.34M | 141.07M | 130.34M | 364K |
| Goodwill | 5.72M | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.1M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 23.16M | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 8.14M | 3.41M | 639K | 8.76M | 11.73M |
| Total Non-current Assets | 145.96M | 212.75M | 164.87M | 139.1M | 12.09M |
| Total Assets | 609.98M | 482.13M | 325.63M | 263.57M | 203.52M |
| Account Payables | 5.57M | 2.36M | 1.21M | 659K | 779K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 524K | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.66M | 4.23M | 1.22M | 2.07M | 2.52M |
| Total Current Liabilities | 41.36M | 32.79M | 10.56M | 7.9M | 4.84M |
| Long-term Debt | 0 | 72.35M | 81.43M | 84.19M | 84.81M |
| Deferred Tax Liabilities | 2.43M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 11M | 8.21M | 4.94M | 1.03M | 8K |
| Total Non-current Liabilities | 13.43M | 85.74M | 89.24M | 86.24M | 84.81M |
| Total Liabilities | 54.78M | 118.52M | 99.8M | 94.13M | 89.66M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (201.72M) | (424.89M) | (580.98M) | (655.12M) | (726.49M) |
| Accumulated OCI | (87K) | (493K) | (348K) | (228K) | (583K) |
| Other Stockholders Equity | 0 | 0 | 0 | (0) | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 555.2M | 363.61M | 225.83M | 169.44M | 113.87M |
| Total Debt | 0 | 79.9M | 86.05M | 86.89M | 85.18M |
| Net Debt | (37.59M) | 36.19M | 76.86M | 78.08M | 78.54M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $5.0M |
| Short-term Investments | $69.5M |
| Receivables | $28.0K |
| Other Current | $113.7M |
| Total Current Assets | $188.3M |
| PP&E (Net) | $172.0K |
| Other Non-current | $12.0M |
| Total Non-current Assets | $12.1M |
| Total Assets | $200.4M |
Analysis
Selected assets total $200.4M for Latest. The largest visible component is Other Current at $113.7M, about 56.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | |
| 8-K | Current report | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jun 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jun 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jun 12, 2026 |
How much cash does TIL have?
Instil Bio, Inc. (TIL) reported $6.64M in cash and equivalents in fiscal 2025.
How much debt does TIL carry?
Instil Bio, Inc. (TIL) reported $85.18M of total debt, with net debt of $78.54M.
Continue the stock analysis
Jump to another research area for this company.